Integer (NYSE:ITGR) Sets New 12-Month High at $131.17

Integer Holdings Co. (NYSE:ITGR)’s stock price reached a new 52-week high on Thursday . The stock traded as high as $131.17 and last traded at $131.17, with a volume of 52061 shares trading hands. The stock had previously closed at $128.36.

Analyst Ratings Changes

Several analysts recently weighed in on ITGR shares. Oppenheimer assumed coverage on Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price objective on the stock. Benchmark reaffirmed a “buy” rating and issued a $130.00 price objective on shares of Integer in a research note on Friday, August 2nd. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $133.86.

Integer Stock Performance

The firm has a market capitalization of $4.33 billion, a P/E ratio of 44.70, a P/E/G ratio of 1.81 and a beta of 1.09. The stock has a fifty day simple moving average of $122.98 and a two-hundred day simple moving average of $118.60. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating the consensus estimate of $1.24 by $0.06. The firm had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company’s quarterly revenue was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.14 earnings per share. On average, research analysts predict that Integer Holdings Co. will post 5.31 EPS for the current year.

Insider Activity at Integer

In related news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Quest Partners LLC boosted its position in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares during the last quarter. GAMMA Investing LLC boosted its position in Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 142 shares during the last quarter. Principal Securities Inc. purchased a new position in Integer in the fourth quarter worth $67,000. Headlands Technologies LLC purchased a new position in Integer in the first quarter worth $106,000. Finally, Innealta Capital LLC purchased a new position in Integer in the second quarter worth $110,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.